Diagnosis dan tatalaksana terbaru penyakit pleura

Ni Putu Nita Pranita(1Mail),
(1) universitas lampung, Indonesia

Mail Corresponding Author

Full Text:    Language : Ind


Pleural effusion is a common problem. Pleural effusion developed as a sequel to the underlying disease process, including pressure/volume imbalance, infection, and malignancy. In addition to pleural effusion, persistent air leak after surgery and bronchopleural fistula remain a challenge by a physician. An understanding of the pleural disease, including its diagnosis and management, has made an extraordinary step. The introduction of molecular detection of organism-specific infections, risk stratification, and improvement in the non-surgical treatment of patients with pleural infection are all within reach and maybe the standard of care shortly. This article discusses the role of existing techniques, and some of the more recent ones, which are now available for establishing the diagnosis of pleural disease. The initial approach to diagnosis usually begins by distinguishing between transudates and exudates, based on the concentration of protein and lactate dehydrogenase (LDH) in pleural fluid. The exact role of amylase and LDH can provide additional information towards the differential diagnosis of various exudative pleural effusions. With newer cytochemical staining techniques in pleural fluid, diagnostic results of malignant pleural effusion can increase by up to 80%. Ultrasound (US) and thoracic computed tomographic (CT) scans have further improved the diagnosis of undiagnosed pleural effusion. The reappearance of thoracoscopy as the latest diagnostic and therapeutic tool (e.g., Pleurodesis) for undiagnosed or recurrent pleural effusions. Management of malignant pleural effusion continues to develop with the introduction of tunneled pleural catheters and chemical pleurodesis procedures. Advances in the diagnostic and therapeutic evaluation of pleural disease and what appears to be an increasing multidisciplinary interest in a doctor managing patients with pleural disease.


Diagnosis; Management; Pleural disease; Pleural effusion; Pneumothorax


  1. Almeida, Antunes N, Leal, Figueiredo L. Imaging of Pleural Effusion: Comparing Ultrasound, X-Ray and CT findings. Eur Soc Radiol. 2017;1(1):1–18.
  2. Beaudoin S, Gonzalez A V. Evaluation of the patient with pleural effusion. Cmaj. 2018;190(10): E291-5.
  3. Bode-Lesniewska B. Flow cytometry and effusions in lymphoproliferative processes and other hematologic neoplasias. Acta Cytol. 2016;60(4):354– 64.
  4. Brogi E, Gargani L, Bignami E, Barbariol F, Marra A, Forfori F, et al. Thoracic ultrasound for pleural effusion in the intensive care unit: A narrative review from diagnosis to treatment. Crit Care. 2017;21(1):1–11.
  5. Desai NR, Lee HJ. Diagnosis and management of malignant pleural effusions: State of the art in 2017. J Thorac Dis. 2017;9(7): S1111-22.
  6. Donnenberg AD, Luketich JD, Dhupar R, Donnenberg VS. Treatment of malignant pleural effusions: The case for localized immunotherapy. J Immunother Cancer. 2019;7(1):5–9.
  7. Ferreiro L, San José ME, Valdés L. Management of Parapneumonic Pleural Effusion in Adults. Arch Bronconeumol. 2015;51(12):637–46.
  8. Incekara FO, Tikici DK, Nomenoglu H. Pleural Effusion. Insights Chest Dis. 2018;3(1):1–7.
  9. Kartoun U. Improving the management of spontaneous pneumothorax. Eur Respir J. 2018;52(6):13993003. 25. Sano A. Multidisciplinary team approach for complicated pneumothorax. J Thorac Dis. 2018;10(13): S2109-10.
  10. Light RW. Tuberculous pleural effusion. Turk Torak's Derg. 2015;16(1):1–9.
  11. Oudart JB, Pax C, Bennani-Smires B, Ramont L. Milky pleural fluid. Clin Chem. 2016;62(2):315–7. 17.
  12. Psallidas I, Kalomenidis I, Porcel JM, Robinson BW, Stathopoulos GT. Malignant pleural effusion: From bench to bedside. Eur Respir Rev. 2016;25(140):189–98.
  13. Rosenstengel A. Pleural infectioncurrent diagnosis and management. J Thorac Dis. 2012;4(2):186–93.
  14. Shibaki R, Murakami S, Shinno Y, Matsumoto Y, Goto Y, Kanda S, et al. Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer. Thorac Cancer. 2019;10(4):815–22.
  15. Saguil A, Wyrick K, Hallgren J. Diagnostic approach to pleural effusion. Am Fam Physician. 2014;90(2):99–104.
  16. Villena Garrido V, Cases Viedma E, Fernández Villar A, de Pablo Gafas A, Pérez Rodríguez E, Porcel Pérez JM, et al. Recommendations of diagnosis and treatment of pleural effusion. Update. Arch Bronconeumol. 2014;50(6):235– 49.
  17. Vorster MJ, Allwood BW, Diacon AH, Koegelenberg CFN. Tuberculous pleural effusions: Advances and controversies. J Thorac Dis. 2015;7(6):981–91.
  18. Wang XJ, Yang Y, Wang Z, Xu LL, Wu YB, Zhang J, et al. Efficacy and safety of diagnostic thoracoscopy in undiagnosed pleural effusions. Respiration. 2015;90(3):251–5.
  19. Yusnida, A. M, Widodo, C. E, Adi, K. Chest XRay Segmentation to Calculate Pleural Effusion Index in Patient with Dengue Hemorrhagic Fever. Int J Innov Res Adv Eng. 2017;4(7):2015–8.

Article Metrics

 Abstract Views : 102 times
 Fulltext Downloaded : 1012 times


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.